PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BeiGene, Ltd. (BGNE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS07725L1026
CUSIP07725L102
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$16.82B
EPS-$8.45
Revenue (TTM)$2.46B
Gross Profit (TTM)-$511.06M
EBITDA (TTM)-$1.12B
Year Range$132.95 - $272.49
Target Price$275.27
Short %5.88%
Short Ratio6.13

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BGNE

BeiGene, Ltd.

Popular comparisons: BGNE vs. COST, BGNE vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BeiGene, Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%200.00%300.00%400.00%500.00%600.00%OctoberNovemberDecember2024FebruaryMarch
447.60%
174.43%
BGNE (BeiGene, Ltd.)
Benchmark (^GSPC)

S&P 500

Returns By Period

BeiGene, Ltd. had a return of -14.02% year-to-date (YTD) and -29.50% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-14.02%10.04%
1 month-3.23%3.53%
6 months-19.30%22.79%
1 year-29.50%32.16%
5 years (annualized)3.28%13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-17.81%11.75%
2023-3.11%-13.34%3.56%0.35%-3.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for BeiGene, Ltd. (BGNE) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
BGNE
BeiGene, Ltd.
-0.62
^GSPC
S&P 500
2.76

Sharpe Ratio

The current BeiGene, Ltd. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.62
2.76
BGNE (BeiGene, Ltd.)
Benchmark (^GSPC)

Dividends

Dividend History


BeiGene, Ltd. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-61.53%
0
BGNE (BeiGene, Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BeiGene, Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BeiGene, Ltd. was 69.96%, occurring on May 11, 2022. The portfolio has not yet recovered.

The current BeiGene, Ltd. drawdown is 61.53%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-69.96%Sep 20, 2021163May 11, 2022
-50.63%Jun 11, 201899Oct 29, 2018428Jul 14, 2020527
-34.68%Feb 17, 2021130Aug 20, 202118Sep 16, 2021148
-30.62%Oct 11, 201725Nov 14, 201743Jan 18, 201868
-30.1%Oct 19, 202033Dec 3, 202028Jan 14, 202161

Volatility

Volatility Chart

The current BeiGene, Ltd. volatility is 15.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%OctoberNovemberDecember2024FebruaryMarch
15.84%
2.82%
BGNE (BeiGene, Ltd.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BeiGene, Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items